Live Chat

Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Jan 21, 03:22

Novavax, Inc. (NVAX) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025

Novavax Inc
Webhose 2025 Jan 15, 00:00

Novavax (NVAX) Rises But Trails Market: What Investors Should Know - January 15, 2025 - Zacks.com

Novavax Inc
Webhose 2025 Jan 13, 19:12

JPMorgan's top short ideas for 2025

Novavax Inc
Webhose 2025 Jan 08, 18:21

Novavax (NASDAQ:NVAX) Stock Price Down 8.2% - Time to Sell?

Novavax Inc
Webhose 2025 Jan 08, 02:10

Vaccine stocks rise in premarket trading amid a jump in number of flu cases By Investing.com

Novavax Inc
Webhose 2025 Jan 08, 00:00

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - January 8, 2025 - Zacks.com

Novavax Inc
Webhose 2025 Jan 08, 00:00

Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength? - January 8, 2025 - Zacks.com

Novavax Inc
Webhose 2025 Jan 07, 23:14

Health Care Up as Vaccine Makers Surge - Health Care Roundup | Morningstar

Novavax Inc
Webhose 2025 Jan 07, 18:30

Options Alert: Why Novavax (NVAX) Could Be the Biotech Hero of Trump 2.0

Novavax Inc
Webhose 2025 Jan 07, 17:43

Novavax Target of Unusually High Options Trading (NASDAQ:NVAX)

Novavax Inc
Webhose 2025 Jan 07, 17:43

Novavax (NASDAQ:NVAX) Sees Large Volume Increase - Should You Buy?

Novavax Inc
Webhose 2025 Jan 07, 15:50

Why Vaccine Stocks, Lucid (LCID) Are Rallying

Novavax Inc
Webhose 2025 Jan 07, 04:54

Moderna stock gains on rising flu cases By Investing.com

Novavax Inc
Webhose 2025 Jan 06, 04:06

Vaccine developer stocks rise as flu activity escalates By Investing.com

Novavax Inc
Webhose 2025 Jan 05, 09:56

Novavax, Inc. (NASDAQ:NVAX) Director Sells $43,200.00 in Stock

Novavax Inc
Webhose 2025 Jan 03, 00:53

Novavax, Inc. (NASDAQ:NVAX) Director James F. Young Sells 4,600 Shares

Novavax Inc
Webhose 2025 Jan 03, 00:53

Rachel K. King Sells 4,150 Shares of Novavax, Inc. (NASDAQ:NVAX) Stock

Novavax Inc
Webhose 2025 Jan 03, 00:53

Novavax, Inc. (NASDAQ:NVAX) Director James F. Young Sells 5,400 Shares

Novavax Inc
Webhose 2025 Jan 02, 17:29

Novavax (NASDAQ:NVAX) Stock Price Up 6.6% - Should You Buy?

Novavax Inc
Webhose 2025 Jan 02, 13:48

Novavax director Rachel King sells $37,435 in stock By Investing.com

Novavax Inc
Webhose 2025 Jan 02, 13:46

Novavax director James Young sells shares worth $82,208 By Investing.com

Novavax Inc
Webhose 2025 Jan 02, 00:00

F James Young - Insider Monkey

Novavax Inc
Webhose 2025 Jan 02, 00:00

Novavax Inc (NVAX) - Insider Monkey

Novavax Inc
Webhose 2024 Dec 31, 05:40

Novavax completes $200 million facility sale to Novo Nordisk By Investing.com

Novavax Inc
Webhose 2024 Dec 30, 19:38

Novavax (NASDAQ:NVAX) Stock Price Down 5.8% - Time to Sell?

Novavax Inc
Webhose 2024 Dec 28, 08:28

Novavax, Inc. (NASDAQ:NVAX) Stock Holdings Boosted by Franklin Resources Inc.

Novavax Inc
Webhose 2024 Dec 24, 08:55

Geode Capital Management LLC Has $44.25 Million Stake in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 24, 08:03

Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Analysts

Novavax Inc

Latest news

Info

Spread

0.07

Spread (%)

0.7973 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1411229824

Shares Outstanding

160184992

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date 

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-2.18

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)
view_all_instruments
Trustpilot
Live Chat